{"id":"W2105020329","doi":"10.1158/1535-7163.mct-12-1150","title":"Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Fibroblast growth factor receptor 3; Bladder cancer; Cancer research; Fibroblast growth factor receptor; Cancer; Urothelial Cell; Medicine; Fibroblast growth factor receptor 2; Targeted therapy; Monoclonal antibody; Fibroblast growth factor receptor 4; Fibroblast growth factor; Receptor; Antibody; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009351924,0.0004141403,0.0002799219,0.0001480603,0.00009249847,0.0001131962,0.0004956377,0.000324275,0.003356928],"category_scores_gemma":[0.00001583765,0.0003930984,0.0001771394,0.0003655288,0.0001725989,0.00002549396,0.0001555501,0.0003464289,0.0001377591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001506267,"about_ca_system_score_gemma":0.0004133506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005729218,"about_ca_topic_score_gemma":0.0001187092,"domain_scores_codex":[0.9974574,0.0001774125,0.0003832381,0.0007057245,0.0005247514,0.0007515163],"domain_scores_gemma":[0.9988502,0.00001966929,0.0001132337,0.0005022326,0.0003454488,0.000169172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007773376,0.000100178,0.01301771,0.00004310952,0.0003266336,0.000002549442,0.0002348658,0.0001437681,0.9815632,0.00008897213,0.001904299,0.002497015],"study_design_scores_gemma":[0.001195584,0.0002525326,0.02151522,0.00007803017,0.00001916713,0.000003162691,0.00006176302,0.0006908687,0.9483557,0.0005840313,0.02660364,0.000640322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851778,0.005475115,0.002882008,0.004494231,0.0002144599,0.001045946,0.0002704745,0.00003987746,0.0004001099],"genre_scores_gemma":[0.9904511,0.0008083694,0.0007999794,0.00574032,0.0002353714,0.0007099166,0.0001090547,0.0001288014,0.001017094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03320749,"threshold_uncertainty_score":0.9998521,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02118418005377775,"score_gpt":0.2929432735027572,"score_spread":0.2717590934489795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}